TrialAnnals of surgical oncology2026

Two-Year Outcomes after Direct-to-Surgery in Good Prognosis Margin-Clear Stage II or III Rectal Cancer: The QuickSilver Study.

Erin D Kennedy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.